Literature DB >> 14484759

Histopathological features of muscle in the preclinical stages of muscular dystrophy.

C M PEARSON.   

Abstract

Entities:  

Keywords:  MUSCULAR DYSTROPHY/pathology

Mesh：

Year:  1962        PMID： 14484759     DOI： 10.1093/brain/85.1.109

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  25 in total

1.  HISTOLOGIC ALTERATIONS IN PRECLINICAL MOUSE MUSCULAR DYSTROPHY.

Authors:  A C PLATZER; W H CHASE
Journal:  Am J Pathol       Date:  1964-06       Impact factor: 4.307

2.  MYOPATHIC CHANGES IN A MUSCULAR DYSTROPHY CARRIER.

Authors:  V DUBOWITZ
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-08       Impact factor: 10.154

3.  SERUM ENZYME VARIATIONS AND HISTOLOGICAL ABNORMALITIES IN THE CARRIER STATE IN DUCHENNE DYSTROPHY.

Authors:  J STEPHENS; E LEWIN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-04       Impact factor: 10.154

4.  X-chromosome mosaicism in females with muscular dystrophy.

Authors:  C M PEARSON; W M FOWLER; S W WRIGHT
Journal:  Proc Natl Acad Sci U S A       Date:  1963-07       Impact factor: 11.205

5.  Muscular Dystrophy and Related Disorders.

Authors:  V Dubowitz
Journal:  Postgrad Med J       Date:  1965-06       Impact factor: 2.401

Review 6.  Temporal characteristics of botulinum neurotoxin therapy.

Authors:  Frank J Lebeda; Regina Z Cer; Robert M Stephens; Uma Mudunuri
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

7.  The effect of exercise on the progress of the myopathy in dystrophic hamster muscle fibres.

Authors:  K F Howells; G Goldspink
Journal:  J Anat       Date:  1974-04       Impact factor: 2.610

8.  Creatine kinase activity in the Torpedo electrocyte and in the nonreceptor, peripheral v proteins from acetylcholine receptor-rich membranes.

Authors:  F J Barrantes; G Mieskes; T Wallimann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy.

Authors:  K Folkers; R Nakamura; G P Littarru; H Zellweger; J B Brunkhorst; C W Williams; J H Langston
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  MiR-351 transiently increases during muscle regeneration and promotes progenitor cell proliferation and survival upon differentiation.

Authors:  Yongxin Chen; David W Melton; Jonathan A L Gelfond; Linda M McManus; Paula K Shireman
Journal:  Physiol Genomics       Date:  2012-09-11       Impact factor: 3.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.